Streetbeat News

Products Services

ESEA

Euroseas Ltd. (NASDAQ:ESEA) has announced a time charter contract for its new fuel-efficient 1,800 teu feeder containership, M/V Pepi Star, for 23-25 months at a daily rate of $24,250. The vessel is expected to be delivered on July 19, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:06 pm

AVGO

MRVL

NVDA

Steve Cohen's Point72 Asset Management is launching a new hedge fund focused on AI stocks, aiming to raise $1 billion. The fund will invest in and bet against AI hardware and semiconductor companies like Nvidia, Broadcom, and Marvell Technology. Managed by Eric Sanchez, the fund is expected to start operations late this year or early 2025.

Portfolio Pulse from Vaishali Prayag

June 18, 2024 | 8:06 pm

GYRE

Gyre Therapeutics has announced the publication of a manuscript in the Journal of Gastroenterology and Hepatology. The manuscript highlights the potential of Hydronidone (F351) as a therapy for liver fibrosis through the apoptotic pathway in hepatic stellate cells.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:06 pm

BTCUSD

SMH

SPY

Retail sales have declined, while chip stocks continue to rise. Bitcoin has fallen below $65,000.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:03 pm

PNTG

The Pennant Group has entered into a management and consulting services agreement to support Hartford HealthCare at Home. The agreement involves providing operational support to Hartford's home health and hospice business.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:03 pm

AKLI

Akili has received FDA clearance for EndeavorOTC (AKL-T01) as an over-the-counter treatment for adults with Attention-deficit/Hyperactivity Disorder (ADHD).

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:02 pm

CRSR

SNX

Corsair has announced a partnership with TD SYNNEX to enhance customer relationships and support. The collaboration aims to offer tailored solutions and ensure consistent communication.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:00 pm

RDHL

RedHill Biopharma has received a Notice of Allowance for its U.S. Patent Application 17/900,235, titled 'BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)'.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:58 pm

NXL

Nexalin Technology shares are trading higher after the company was awarded a US patent on 'Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimer's and Dementia.'

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:56 pm

NXL

Nexalin Technology has been awarded U.S. Patent #12011591 for its transcranial alternating current dynamic frequency stimulation (TACS) method, aimed at treating Alzheimer's and Dementia.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:52 pm